echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Taking care of patients with IgG4-related diseases, we should be more careful with the screening of these two types of tumors!

    Taking care of patients with IgG4-related diseases, we should be more careful with the screening of these two types of tumors!

    • Last Update: 2022-01-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    IgG4-related disease (IgG4-RD) is a chronic autoimmune disease, a chronic fibroinflammatory autoimmune disease with multisystem involvement


    immunity

    To date, no meta-analysis has assessed the risk of malignancy in IgG4-RD


    A total of 10 studies were included in this paper


    Meta-analysis results

    All studies reported overall SIR for malignancies


    diagnosis

    Patients with IgG4-RD had an increased risk of malignancy (SIR = 2.


    I 2 Pancreatic cancer 3 Lymphoma 3Stomach cancer 3 Lung cancer 3

    To further understand sources of heterogeneity, subgroup analyses were performed by study quality, geographic region, and mean follow-up time (Table 2)


    [6], Ahn[3] [10] , I 2 0%, P Statistics P P , P Management Screening

    Original source:

    Tingfeng Yu , et al.


    Tingfeng Yu Arthritis Res Ther.
    Arthritis Res Ther.
    Published online 2022 Jan 5.
    doi:10.
    1186/s13075-021-02652-2 10.
    1186/s13075-021-02652-2Leave

    a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.